Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...

Hemolytic anemia occurs when red blood cells are destroyed faster than they can be replaced. The loss of red blood cells ...

Autoimmune hemolytic anemia is a rare red blood cell disorder and an immune disorder. It happens when the body produces antibodies that destroy the red blood cells. Hemolytic anemia develops when ...

Hemolytic disease of the newborn is a type of anemia that begins during pregnancy. It can cause serious illness in a newborn, but it may be diagnosed during prenatal screening and treated to avoid ...

China: CAR T-cell therapy, already in use for certain B-cell–driven autoimmune diseases such as lupus, has now demonstrated ...

In the era of Rhesus (Rh) immune globulin treatment, the non-D Rh antibodies are an increasingly significant cause of alloimmune hemolytic disease of the newborn (HDN). 1 While HDN due to anti-e has ...

Mihir Raval, MD, MPH, comments on the difference between cold agglutinin disease and other autoimmune hemolytic anemias. Neil Minkoff, MD: Now, you had mentioned that there are other autoimmune ...

A 59-year-old man with a history of IgG kappa multiple myeloma presented to an outpatient facility for evaluation of left hip pain, which was found to be a pathologic fracture. He has had 2 autologous ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

The hemolytic–uremic syndrome is a thrombotic complication of Escherichia coli O157:H7 infection. It is not known whether the coagulation abnormalities precede, and potentially cause, this disorder.

The US Food and Drug Administration (FDA) has approved ravulizumab (Ultomiris, Alexion Pharmaceuticals) to inhibit complement-mediated thrombotic microangiopathy (TMA) in adults and children age 1 ...